In our study, we found that STI 571 could prevent PHB2 tyrosine phosphorylation to improve mitophagy and reduce oxidative stress, which provided a basis for further testing STI 571 as a neuroprotective drug for Parkinson's disease. This evidence concerns the gene PHB2 and Parkinson disease.